Skip to content

Embosphere® 00884450106051Recalls & reported problems

Biosphere Medical · Class 2 · Implant

All models of Embosphere (18)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00884450106051), received between Apr 13, 2026 and Jul 15, 2026 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 2 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 1 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Thrombosis/Thrombus1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 15, 2026Adverse Event Without Identified Device or Use Problem

    LITTLE, M. W., O'GRADY, A., BRIGGS, J., GIBSON, M., SPEIRS, A., AL-REKABI, A., YOONG, P., ARIYANAYAGAM, T., DAVIES, N., TAYTON, E., TAVARES, S., MACGILL, S., MCLAREN, C., & HARRISON, R. (2024). GENICULAR ARTERY EMBOLISATION IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE (GENESIS) USING PERMANENT MICROSPHERES: LONG-TERM RESULTS. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 47(12), 1750-1762. HTTPS://DOI.ORG/10.1007/S00270-024-03752-7 WAS REVIEWED DURING INTERNAL QUALITY SYSTEM ACTIVITIES. THE PUBLICATION DESCRIBES ONE PATIENT UNDERGOING GAE THAT DEVELOPED A POPLITEAL DEEP VEIN THROMBOSIS (DVT) 15-DAYS POST-INTERVENTION. THE VENOUS THROMBUS WAS NOT DIRECTLY RELATED TO GAE. MOREOVER, IT WAS RELATED TO IMMOBILITY IN THE POST-OPERATIVE PERIOD. THIS COMPLICATION HIGHLIGHTS THE IMPORTANCE OF EARLY MOBILIZATION POST GAE.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25829662 ↗
  • MalfunctionApr 23, 2026Device Contamination with Chemical or Other Material

    IT WAS REPORTED THAT DURING PREP FOR A HEPATIC ARTERY EMBOLIZATION, A FOREIGN MATERIAL RESEMBLING A HAIR WAS FOUND IN THE SYRINGE. THIS PRODUCT WAS NOT USED FOR THE PROCEDURE. A NEW DEVICE WAS USED INSTEAD. NO INJURY OR ADDITIONAL MEDICAL TREATMENTS WERE REQUIRED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24964576 ↗
  • MalfunctionApr 13, 2026Break

    THE CUSTOMER REPORTS THE TIP OF THE SYRINGE WAS BROKEN PRIOR TO SURGERY. NO PATIENT INVOLVEMENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24865378 ↗

Other AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS devices

All AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page